Compliance

Pro Pharma Peptides – Compliance & Legal Overview

Effective Date: January 31, 2026

At Pro Pharma Peptides, compliance, transparency, and ethical responsibility are central to our operations. This overview outlines our company structure, regulatory positioning, and internal practices. It is intended to provide clarity to customers, financial institutions, regulatory authorities, and legal professionals regarding our business model and product classification.

1. Company Legal Structure

Pro Pharma Peptides is a legally registered business operating in good standing. We function exclusively as a research chemical supplier.

We do not operate as:

  • A pharmacy
  • A compounding facility
  • A medical provider
  • A dietary supplement distributor

Our products are supplied strictly for laboratory research purposes.

2. Intended Use of Products

All products offered by Pro Pharma Peptides are intended solely for laboratory research and analytical applications. They are:

  • Not approved by the U.S. Food and Drug Administration (FDA)
  • Not intended for human or animal consumption
  • Not intended for therapeutic, diagnostic, or medical use
  • Not intended for compounding, repackaging, or resale as drugs, dietary supplements, or cosmetics

These restrictions are clearly communicated through:

  • Terms of Service
  • Product labels and inserts
  • Checkout acknowledgments and disclaimers
  • Shipping documentation

3. FDA Compliance – Research Use Only (RUO)

All products are labeled in accordance with 21 CFR 809.10(c)(2)(i) under the “Research Use Only” (RUO) designation.

Each product includes RUO-compliant labeling such as:

  • “For Research Use Only”
  • “Not for Human or Animal Use”
  • No dosing, administration, or reconstitution instructions

Products are not intended for diagnostic procedures or clinical investigations.

4. Product Testing & Documentation

To maintain quality assurance and transparency, all Pro Pharma Peptides products undergo analytical verification, including:

  • High-Performance Liquid Chromatography (HPLC)
  • Mass Spectrometry testing

Each product listing includes a downloadable Certificate of Analysis (COA) confirming purity and identity.

5. Packaging, Labeling & Shipment

Our packaging and shipping practices are designed to reflect professionalism, discretion, and regulatory compliance:

  • Tamper-evident packaging with clear RUO labeling
  • No medical symbols or injection-related terminology
  • QR code linking to the product’s Certificate of Analysis
  • Verification through third-party laboratory testing
  • Discreet, non-descriptive exterior shipping materials

If bacteriostatic water is included in a shipment, it is clearly labeled:

“For Laboratory Research Use Only. Not for injection or clinical use.”

6. Communication & Customer Support Policy

Pro Pharma Peptides does not provide guidance regarding:

  • Dosing or administration
  • Reconstitution or preparation
  • Human or veterinary application
  • Consumption-related storage practices

Requests of this nature will be declined and redirected to our Terms of Service and applicable policies.

7. Enforcement, Monitoring & Misuse Reporting

We actively monitor order activity and enforce compliance measures, including:

  • Canceling orders that suggest non-research intent
  • Restricting or suspending accounts that violate company policies
  • Disclaiming responsibility for third-party content (forums, reviews, social media)
  • Cooperating with regulatory and law enforcement authorities when required

All customers must agree at checkout to indemnify Pro Pharma Peptides against liability arising from misuse.

8. Regulatory & Financial Platform Cooperation

This overview is published to support compliance evaluations by:

  • Payment processors (e.g., Shopify, Stripe, Square)
  • Shipping carriers
  • Regulatory authorities
  • Industry oversight entities

By maintaining clear documentation, consistent labeling, and transparent operational standards, Pro Pharma Peptides reinforces its commitment to responsible research supply and reduces the risk of regulatory misclassification.